To hear about similar clinical trials, please enter your email below
Trial Title:
Demographics, Characteristics and Outcomes of Male Breast Cancer Patients at Methodist Health System
NCT ID:
NCT06133647
Condition:
Ductal Carcinoma in Situ
Invasive Lobular Breast Carcinoma
Conditions: Official terms:
Carcinoma
Breast Neoplasms
Carcinoma in Situ
Carcinoma, Ductal
Breast Neoplasms, Male
Carcinoma, Intraductal, Noninfiltrating
Carcinoma, Lobular
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Retrospective
Intervention:
Intervention type:
Procedure
Intervention name:
managing Male Breast Cancer Patients at Methodist Health System
Description:
To determine the number of MBC cases as well as the demographics, characteristics, and
outcomes of MBC patients at Methodist Health System (MHS).
Other name:
Larger studies in MBC are needed to provide more clinical data to help guide treatment.
Summary:
To determine the number of MBC cases as well as the demographics, characteristics, and
outcomes of MBC patients at Methodist Health System (MHS).
Detailed description:
Male breast cancer (MBC) is a rare disease without sufficient clinical data supporting
the management and treatment. The treatment of MBC arises from data extrapolated from
female breast cancer (FBC). MBC has higher mortality than FBC. Previous studies have
suggested differences between MBC and FBC; however, treatments remain the same for both.
Larger studies in MBC are needed to provide more clinical data to help guide treatment.
Criteria for eligibility:
Study pop:
- ≥ 18 years of age
- Patients diagnosed with ductal carcinoma in situ or invasive lobular carcinoma of
the breast
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- • ≥ 18 years of age Patients diagnosed with ductal carcinoma in situ or invasive
lobular carcinoma of the breast
Exclusion Criteria:
- 18 years of age
- Prisoners
- Pregnant or breastfeeding
Gender:
All
Minimum age:
18 Years
Maximum age:
85 Years
Locations:
Facility:
Name:
Clinical Research Institute at Methodist Health System
Address:
City:
Dallas
Zip:
75203
Country:
United States
Status:
Recruiting
Contact:
Last name:
Colette N Ndjom, MS
Phone:
410-947-4681
Phone ext:
74681
Email:
ColetteNgoNdjom@mhd.com
Contact backup:
Last name:
Loretta W Bedell, MPH
Phone:
214-947-4680
Phone ext:
74680
Email:
lorettabedell@mhd.com
Investigator:
Last name:
Lauren Hoffman, MD
Email:
Principal Investigator
Facility:
Name:
Clinical Research Institute at Methodist Health System
Address:
City:
Dallas
Zip:
75203
Country:
United States
Status:
Recruiting
Contact:
Last name:
Colette Ngo Ndjom, MS
Phone:
410-947-4681
Phone ext:
74681
Email:
ColetteNgoNdjom@mhd.com
Contact backup:
Last name:
Kasim A Bhimani, BA
Phone:
214-947-4459
Phone ext:
74459
Email:
kasimbhimani@mhd.com
Start date:
May 4, 2023
Completion date:
May 4, 2024
Lead sponsor:
Agency:
Methodist Health System
Agency class:
Other
Source:
Methodist Health System
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06133647
